Br J Dermatol:习惯性逆转疗法治疗特应性皮炎儿童的有效

2017-09-29 MedSci MedSci原创

背景:特应性皮炎的特征为患者或其家族中可见明显的“特应性”特点:①容易罹患哮喘、过敏性鼻炎、湿疹的家族性倾向;②对异种蛋白过敏;③血清中IgE高;④血液嗜酸性粒细胞增多。皮损和瘙痒是特应性皮炎的临床症状(AD)。对成年患者的研究表明,抓挠行为的减少导致了炎症消退和皮肤愈合的改善。目标:本研究的目的是调查改良的习惯逆转治疗(HR)方案是否可用于治疗儿童抓伤,以改善皮肤状况。方法:该研究是一项单盲、随

背景:特应性皮炎的特征为患者或其家族中可见明显的“特应性”特点:①容易罹患哮喘、过敏性鼻炎、湿疹的家族性倾向;②对异种蛋白过敏;③血清中IgE高;④血液嗜酸性粒细胞增多。

皮损和瘙痒是特应性皮炎的临床症状(AD)。对成年患者的研究表明,抓挠行为的减少导致了炎症消退和皮肤愈合的改善。

目标:本研究的目的是调查改良的习惯逆转治疗(HR)方案是否可用于治疗儿童抓伤,以改善皮肤状况。

方法:该研究是一项单盲、随机对照试验,39例患者在随机分组前一周招募到,这些患者被随机分为干预组和对照组。在干预组的参与者接受到打破他们的习惯性抓挠行为的疗法(即HR)+类固醇(糠酸莫米松)治疗,而对照组患者仅接受类固醇治疗。患者在第一个星期进行登记(即基线评估)后接受独立的皮肤科医生评估,然后在治疗三周后和之后八周再次进行评估。主要疗效变量是SCORAD(特应性皮炎得分)的客观变化。

结果:为期三周的治疗结束后,与对照组相比(-23.8,SD 10.1),干预组(-31.9,SD 9.5)的SCORAD得分的平均变化显著(P = 0.027)。八周后随访时,干预组(-31.7,SD 10.4)的SCORAD的平均变化显著(P = 0.0038)高于对照组(-19.7,SD 9.4)。

结论:对抓挠习惯的治疗方法——HR方法结合强力类固醇治疗3周后和第11周,能显著改善皮肤状况。

原始出处:

Norén P, Hagströmer L,et al.The positive effects of habit reversal treatment of scratching in children with atopic dermatitis: A randomised controlled study.Br J Dermatol. 2017 Sep 23. doi: 10.1111/bjd.16009. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=256828, encodeId=843125682838, content=怎样实施逆转性治疗呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/04/355c07748bd28246a802dedc6fdf7421.jpg, createdBy=4cfd1732073, createdName=0348, createdTime=Sun Oct 29 06:40:29 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251628, encodeId=c15625162846, content=最后一点解读亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Oct 09 23:11:45 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249080, encodeId=546924908076, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sat Sep 30 10:23:05 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249003, encodeId=ec05249003d1, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 30 06:50:08 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248961, encodeId=9e4824896198, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4Cr8ibeWnmTmmC1lthicNVicicXTX7Mn9OEib5S1eHg4jhM9usWmW2NBVm6NaJurhgeMl3UJ1gujuaQuIX7icVSa8F4JoFPCfib0Prsk/0, createdBy=b5bb2069360, createdName=cherry bomb, createdTime=Sat Sep 30 02:14:29 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248948, encodeId=9c8424894816, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Sep 30 00:36:15 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-10-29 0348

    怎样实施逆转性治疗呢?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=256828, encodeId=843125682838, content=怎样实施逆转性治疗呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/04/355c07748bd28246a802dedc6fdf7421.jpg, createdBy=4cfd1732073, createdName=0348, createdTime=Sun Oct 29 06:40:29 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251628, encodeId=c15625162846, content=最后一点解读亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Oct 09 23:11:45 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249080, encodeId=546924908076, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sat Sep 30 10:23:05 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249003, encodeId=ec05249003d1, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 30 06:50:08 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248961, encodeId=9e4824896198, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4Cr8ibeWnmTmmC1lthicNVicicXTX7Mn9OEib5S1eHg4jhM9usWmW2NBVm6NaJurhgeMl3UJ1gujuaQuIX7icVSa8F4JoFPCfib0Prsk/0, createdBy=b5bb2069360, createdName=cherry bomb, createdTime=Sat Sep 30 02:14:29 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248948, encodeId=9c8424894816, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Sep 30 00:36:15 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-10-09 虈亣靌

    最后一点解读亮了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=256828, encodeId=843125682838, content=怎样实施逆转性治疗呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/04/355c07748bd28246a802dedc6fdf7421.jpg, createdBy=4cfd1732073, createdName=0348, createdTime=Sun Oct 29 06:40:29 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251628, encodeId=c15625162846, content=最后一点解读亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Oct 09 23:11:45 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249080, encodeId=546924908076, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sat Sep 30 10:23:05 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249003, encodeId=ec05249003d1, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 30 06:50:08 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248961, encodeId=9e4824896198, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4Cr8ibeWnmTmmC1lthicNVicicXTX7Mn9OEib5S1eHg4jhM9usWmW2NBVm6NaJurhgeMl3UJ1gujuaQuIX7icVSa8F4JoFPCfib0Prsk/0, createdBy=b5bb2069360, createdName=cherry bomb, createdTime=Sat Sep 30 02:14:29 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248948, encodeId=9c8424894816, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Sep 30 00:36:15 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 执着追梦

    学习.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=256828, encodeId=843125682838, content=怎样实施逆转性治疗呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/04/355c07748bd28246a802dedc6fdf7421.jpg, createdBy=4cfd1732073, createdName=0348, createdTime=Sun Oct 29 06:40:29 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251628, encodeId=c15625162846, content=最后一点解读亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Oct 09 23:11:45 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249080, encodeId=546924908076, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sat Sep 30 10:23:05 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249003, encodeId=ec05249003d1, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 30 06:50:08 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248961, encodeId=9e4824896198, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4Cr8ibeWnmTmmC1lthicNVicicXTX7Mn9OEib5S1eHg4jhM9usWmW2NBVm6NaJurhgeMl3UJ1gujuaQuIX7icVSa8F4JoFPCfib0Prsk/0, createdBy=b5bb2069360, createdName=cherry bomb, createdTime=Sat Sep 30 02:14:29 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248948, encodeId=9c8424894816, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Sep 30 00:36:15 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 刘煜

    谢谢分享.学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=256828, encodeId=843125682838, content=怎样实施逆转性治疗呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/04/355c07748bd28246a802dedc6fdf7421.jpg, createdBy=4cfd1732073, createdName=0348, createdTime=Sun Oct 29 06:40:29 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251628, encodeId=c15625162846, content=最后一点解读亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Oct 09 23:11:45 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249080, encodeId=546924908076, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sat Sep 30 10:23:05 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249003, encodeId=ec05249003d1, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 30 06:50:08 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248961, encodeId=9e4824896198, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4Cr8ibeWnmTmmC1lthicNVicicXTX7Mn9OEib5S1eHg4jhM9usWmW2NBVm6NaJurhgeMl3UJ1gujuaQuIX7icVSa8F4JoFPCfib0Prsk/0, createdBy=b5bb2069360, createdName=cherry bomb, createdTime=Sat Sep 30 02:14:29 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248948, encodeId=9c8424894816, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Sep 30 00:36:15 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 cherry bomb

    学习了谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=256828, encodeId=843125682838, content=怎样实施逆转性治疗呢?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/04/355c07748bd28246a802dedc6fdf7421.jpg, createdBy=4cfd1732073, createdName=0348, createdTime=Sun Oct 29 06:40:29 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251628, encodeId=c15625162846, content=最后一点解读亮了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon Oct 09 23:11:45 CST 2017, time=2017-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249080, encodeId=546924908076, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Sat Sep 30 10:23:05 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249003, encodeId=ec05249003d1, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Sat Sep 30 06:50:08 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248961, encodeId=9e4824896198, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4Cr8ibeWnmTmmC1lthicNVicicXTX7Mn9OEib5S1eHg4jhM9usWmW2NBVm6NaJurhgeMl3UJ1gujuaQuIX7icVSa8F4JoFPCfib0Prsk/0, createdBy=b5bb2069360, createdName=cherry bomb, createdTime=Sat Sep 30 02:14:29 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248948, encodeId=9c8424894816, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Sep 30 00:36:15 CST 2017, time=2017-09-30, status=1, ipAttribution=)]
    2017-09-30 惠映实验室

    学习了.谢谢.

    0

相关资讯

Allergy:非皮损型特应性皮炎的T细胞克隆与皮损型类似

特应性皮炎的特征为患者或其家族中可见明显的“特应性”特点:①容易罹患哮喘、过敏性鼻炎、湿疹的家族性倾向;②对异种蛋白过敏;③血清中IgE高;④血液嗜酸性粒细胞增多。典型的特应性皮炎具有特定的湿疹临床表现和上述四个特点。又称异位性皮炎、特应性湿疹、Besnier体质性痒疹或遗传过敏性湿疹。临床分三期:婴儿期呈急性或亚急性湿疹状;儿童期及青年期则为亚急性或慢性湿疹状。特应性皮炎(AD)的特点是免疫激活

J Am Acad Dermatol:国际湿疹理事会专家小组建议——特应性皮炎何时需要全身治疗?

虽然大多数特应性皮炎(AD)患者通过局部用药得到了有效的治疗,但仍有少数患者需要全身治疗。但是,目前缺乏可作为系统治疗的决策指南的相关进展。本建议旨在指导临床皮肤科医生如何在特应性皮炎患者中确定适合接受全身治疗的患者,并提供了一个评估的框架。

Allergy:国际湿疹理事会呼吁,皮肤科诊断术语请勿使用“eczema(湿疹)”

关于特应性皮炎或特应性湿疹(AD/AE)的准确命名一直备受争议。但越来越清楚的是,这种疾病的不同命名可能对临床护理、研究和药物开发有着严重的不利影响。为了在国际专家组之间达成对AD/AE命名的共识,研究人员设计了本研究,并将研究结果发表在6月份的Allergy上。国际湿疹理事会(IEC)的评议员和成员完成了一个含有3个问题的调查。至少有90%的回应,以及超过90%者同意该命名时,共识达成。77个I

J Am Acad Dermatol:儿童特应性皮炎的发病年龄与哮喘和季节性过敏症的风险相关

特应性皮炎的发生往往和遗传过敏有关,遗传过敏体质不仅可导致儿童特应性皮炎,也是食物过敏、过敏性鼻炎、过敏性哮喘等一系列过敏疾病的主要内因,这些是孩子在不同年龄段表现出不一样的过敏反应,这就是医生常说的“过敏进行曲”,临床上也称为“特应性皮炎马拉松”。但目前对这种“过敏进行曲”的变异却知之甚少。

上海儿童特应性皮炎频发,“慢病”需长期管理

特应性皮炎是一种慢性、复杂性、炎症性皮肤病。其发病原因比较复杂,与遗传、环境、免疫异常以及皮肤屏障功能等等有关。复旦大学附属华山医院皮肤科主任徐金华教授介绍,作为一种过敏性疾病,特应性皮炎和环境污染程度、城市化发展水平紧密相关。这也是上海地区特应性皮炎频发、发病率明显高于全国水平的主要原因。与普通湿疹不同,特应性皮炎是一种由免疫问题引发的“难治型湿疹”。如果不及时采取科学恰当的治疗,可能会难以摆脱

J Am Acad Dermatol:crisaborole(2%乳膏)治疗轻度至中度特应性皮炎患者的长期安全性研究(AD-303)

局部用药的非甾体PDE4抑制剂crisaborole(2%乳膏),被开发用于治疗儿童及成人轻度至中度特应性皮炎(湿疹,eczema)。2015年7月,crisaborole两项关键III期研究均达到主要终点和次要终点。2015年10月,crisaborole长期安全性研究一线结果表明,crisaborole间歇性使用12个月以上具有良好的耐受性和安全性。2016年12月14日,FDA批准Anaco